Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06356610 · ClinicalTrials.gov registry record · NA

Pharmacokinetic and Subjective Effects of Heated Tobacco Products

A NA study, sponsored by Altria Client Services.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT06356610 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06356610, a NA study, has completed, sponsored by Altria Client Services.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This is a randomized, controlled, six-way crossover clinical study to characterize the nicotine PK (pharmacokinetic) and subjective effects of HTPs (Heated Tobacco Products) comprised of 2 menthol varieties and 2 tobacco flavor varieties (Ploom® HTPs, Japan Tobacco Inc.) in adult menthol and non-menthol combustible cigarette smokers (males and females between the ages of 22 and 65). The study will include participants' UBCC (Usual Brand Combustible Cigarette) and a nicotine gum (Nicorette®) as high and low abuse liability reference products, respectively, to the HTP. Study participation is expected to last up to 34 days, including a 28-day screening period (that includes a 5-day at-home HTP product trial period), and a 6-day in-clinic confinement period (from Check-in \[Day -1\] through the end-of-study \[EOS\] visit on Day 6).

Interventions

  • OTHER Product A
  • OTHER Product B
  • OTHER Product C
  • OTHER Product D
  • OTHER Product E

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-02-06
Est. Completion 2024-12-18
Phase NA

Sponsor

Altria Client Services

10 total trials

What the Registry Record Tells You About NCT06356610

The ClinicalTrials.gov registry entry for NCT06356610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.

NCT06356610 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06356610 about?

NCT06356610 is a clinical study titled "Pharmacokinetic and Subjective Effects of Heated Tobacco Products". This is a randomized, controlled, six-way crossover clinical study to characterize the nicotine PK (pharmacokinetic) and subjective effects of HTPs (Heated Tobacco Products) comprised of 2 menthol varieties and 2 tobacco flavor varieties (Ploom® HTPs, Japan Tobacco Inc.) in adult menthol and non-men...

What is the current status of trial NCT06356610?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2024-02-06. Estimated completion is 2024-12-18.

What interventions are being tested in trial NCT06356610?

The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).

Who is sponsoring clinical trial NCT06356610?

This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.